Charles Schwab’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
Charles Schwab's WGS Position: Q2 2026 in Review
Charles Schwab increased its GeneDx Holdings (WGS) stake by 4.3% in Q2 2026, buying an estimated $416K and bringing the position to 177,937 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.
Charles Schwab first reported a position in WGS in Q3 2021 and has held it in 17 quarters since. The position peaked at $23M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- Charles Schwab held 177,937 shares of GeneDx Holdings worth $12.2M as of Q2 2026.
- Charles Schwab bought 7,322 GeneDx Holdings shares in Q2 2026, an estimated $416K.
- GeneDx Holdings made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2061 holding.
- Charles Schwab first reported a position in GeneDx Holdings in Q3 2021 and has held it in 17 quarters since.
- Charles Schwab's GeneDx Holdings position peaked at $23M in Q4 2025.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.